Track the Oncopeptides AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Oncopeptides AB has logged 13 reports. Market capitalisation: €604.1m. The latest transaction was disclosed on 9 June 2026 (Purchase). Among the most active insiders: Per Wold-Olsen. All data is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€120,994
13 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Buys €120,994n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,500 shares@ €0.39290.0002% mcap76.2% of flowAktieISINISIN SE0009414576FI:A003R706-1
13 of 13 declarations
About Oncopeptides AB
Oncopeptides AB is a biopharmaceutical company focused on developing treatments for hematological cancers. It is listed on the Stockholm Stock Exchange.